Molecular Docking, DFT, and Structural Characterization of Cr(III), Mn(II), and Fe(III) Mixed‐Ligand Complexes With Nifuroxazide and 4‐Chloro‐Pyridine‐2‐Carboxylic Acid: New Perspectives on Antibacterial and Anti‐Inflammatory Activity
Chemistry & Biodiversity · 2026-03 · 23 (3)
DOI: 10.1002/cbdv.202503479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 02.03.2026. Verfasst von Nourah Almulhim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Molecular Docking Simulation, Hydroxybenzoates, Density Functional Theory. Die Arbeit nennt 81 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Faisal University, Deanship of Scientific Research, King Saud University.
Abstract (Originalsprache)
The development of metal‐based therapeutics offers a promising strategy to overcome antimicrobial resistance and enhance anti‐inflammatory efficacy. In this study, three new mixed‐ligand complexes of Cr(III), Mn(II), and Fe(III) with nifuroxazide (NF) and 4‐chloro‐pyridine‐2‐carboxylic acid (CP) were synthesized and comprehensively characterized. Spectroscopic, magnetic, and thermal analyses, supported by DFT calculations, confirmed octahedral coordination geometries, with CrPCNF and FePCNF behaving as 1:1 electrolytes ( Λ m = 40.52 and 40.55 Ω −1 cm 2 mol −1 , respectively), while MnPCNF ( Λ m = 11.32 Ω −1 cm 2 mol −1 ) was non‐electrolytic. Density functional theory revealed reduced HOMO‐LUMO energy gaps and high electrophilicity indices for MnPCNF (3.14 eV; ω = 19.44) and FePCNF (2.71 eV; ω = 20.53), indicating enhanced chemical reactivity relative to the free ligands. Biological evaluation demonstrated a pronounced improvement in antibacterial, antifungal, and anti‐inflammatory activities upon metal complexation. Notably, the FePCNF complex exhibited the highest antibacterial activity (31.0 mm against Bacillus subtilis and 30 mm against Klebsiella pneumoniae ; MIC = 80 µM), superior antifungal efficacy (20 mm inhibition zones; MIC = 100 µM), and the strongest anti‐inflammatory response (25.07% inhibition at 500 µM; IC 50 = 71.23 µM). Molecular docking against Escherichia coli FabH and COX‐2 enzymes corroborated the experimental results, with FePCNF showing the most favorable binding affinities (−8.90 and −9.50 kcal mol −1 , respectively). Overall, these findings proposed that the Fe(III) mixed‐ligand complex might be a promising multifunctional candidate drug for further development as an antimicrobial and anti‐inflammatory agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.
- Department of Chemistry, Faculty of Science, Sohag University, Sohag, Egypt.
ORCID-Profile: Hany M Abd El-Lateef
Förderung
- Deanship of Scientific Research
- King Faisal University
- Deanship of Scientific Research, King Saud University
Zitieren
APA
Almulhim, N., El-Lateef, H. M. A., Khalaf, M. M., & Abdou, A. (2026). Molecular Docking, DFT, and Structural Characterization of Cr(III), Mn(II), and Fe(III) Mixed‐Ligand Complexes With Nifuroxazide and 4‐Chloro‐Pyridine‐2‐Carboxylic Acid: New Perspectives on Antibacterial and Anti‐Inflammatory Activity. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.202503479
Vancouver
Almulhim N, El-Lateef HMA, Khalaf MM, Abdou A. Molecular Docking, DFT, and Structural Characterization of Cr(III), Mn(II), and Fe(III) Mixed‐Ligand Complexes With Nifuroxazide and 4‐Chloro‐Pyridine‐2‐Carboxylic Acid: New Perspectives on Antibacterial and Anti‐Inflammatory Activity. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.202503479
BibTeX
@article{Almulhim2026,
author = {Almulhim, Nourah and El-Lateef, Hany M Abd and Khalaf, Mai M and Abdou, Aly},
title = {Molecular Docking, DFT, and Structural Characterization of Cr(III), Mn(II), and Fe(III) Mixed‐Ligand Complexes With Nifuroxazide and 4‐Chloro‐Pyridine‐2‐Carboxylic Acid: New Perspectives on Antibacterial and Anti‐Inflammatory Activity},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {3},
doi = {10.1002/cbdv.202503479}
}
EUVIMED